Outpace Bio
Outpace Bio develops AI-powered protein design technologies to create engineered cell therapies for cancer treatment. Its platform programs cells to improve potency, specificity, persistence, and safety, aiming to make cell therapies effective, safe, and scalable across diverse cancer indications. The organization’s mission is to cure cancer by overcoming biological barriers through advanced cellular engineering.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2020
- Type
- Corporation Seattle business license
- Employees
- 74
- Registered name
- Outpace Bio Inc Seattle business license
- Stage
- Series A
- Members see funding amounts. .
Is this your organization? Claim it
Members see Outpace Bio's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 5-
Marc Lajoie Executive Officer, Director, Promoter, Co-founder & Chief Executive Officer
-
Scott Boyken Executive Officer, Director, Promoter, Co-founder & Chief Innovation Officer
-
Aaron Foster Executive, Executive Officer, Chief Scientific Officer